These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2943981

  • 1. Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
    Johansson AM, Karlén A, Grol CJ, Sundell S, Kenne L, Hacksell U.
    Mol Pharmacol; 1986 Sep; 30(3):258-69. PubMed ID: 2943981
    [Abstract] [Full Text] [Related]

  • 2. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP, Markstein R.
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
    Arvidsson LE, Karlén A, Norinder U, Kenne L, Sundell S, Hacksell U.
    J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
    Johansson AM, Fredriksson K, Hacksell U, Grol CJ, Svensson K, Carlsson A, Sundell S.
    J Med Chem; 1990 Oct; 33(10):2925-9. PubMed ID: 2120444
    [Abstract] [Full Text] [Related]

  • 7. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
    Johansson AM, Nilsson JL, Karlén A, Hacksell U, Svensson K, Carlsson A, Kenne L, Sundell S.
    J Med Chem; 1987 Jul; 30(7):1135-44. PubMed ID: 3599021
    [Abstract] [Full Text] [Related]

  • 8. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
    Malmberg A, Nordvall G, Johansson AM, Mohell N, Hacksell U.
    Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492
    [Abstract] [Full Text] [Related]

  • 9. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
    Kuipers W, Kruse CG, van Wijngaarden I, Standaar PJ, Tulp MT, Veldman N, Spek AL, IJzerman AP.
    J Med Chem; 1997 Jan 31; 40(3):300-12. PubMed ID: 9022796
    [Abstract] [Full Text] [Related]

  • 15. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB, Guan JH, Neumeyer JL, Seeman P.
    Mol Pharmacol; 1985 Feb 31; 27(2):193-9. PubMed ID: 3969068
    [Abstract] [Full Text] [Related]

  • 16. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G.
    Exp Neurol; 1997 Jul 31; 146(1):74-80. PubMed ID: 9225740
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, Neve KA.
    J Med Chem; 1998 Oct 22; 41(22):4385-99. PubMed ID: 9784114
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH, Kline RH, Geter-Douglass B, Izenwasser S, Witkin JM, Newman AH.
    J Med Chem; 1996 Aug 16; 39(17):3423-8. PubMed ID: 8765528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.